Navigation Links
Major cancer societies to support new Wiley Open Access Journal
Date:1/17/2012

Hoboken, NJ -- Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., today announced the launch of Cancer Medicine, a new Wiley Open Access journal. Cancer Medicine is a peer reviewed, open access, interdisciplinary journal providing rapid publication of cutting edge research from global biomedical and clinical researchers across all the oncologic specialties in cancer biology, clinical cancer research and cancer prevention. The journal's promise of full global reach is reinforced by its editorial leadership and support from prestigious journals and societies. Cancer Medicine has unprecedented support from three major cancer societies: American Cancer Society (ACS), Union for International Cancer Control (UICC) and Japanese Cancer Association (JCA).

Chris Graf, Publisher at Wiley-Blackwell for Cancer Medicine speaks about the societies' involvement in the new journal, "We are thrilled that the ACS, the UICC, and the JCA are collaborating with us to launch our new open access journal, Cancer Medicine. This unique partnership of top-flight organizations reaches around the globe and is a great fit for Cancer Medicine's truly global editorial ambitions."

Jesper Konradsen, Journal Publishing Manager adds, "We believe that by supporting the journal these societies lead the way for others by showing that while publishing models may change, the core value of successful journals remain the same: to serve as the forums for what the research community considers the most significant current research."

Cancer Medicine is steered by Editor-in-Chief Dr. Qingyi Wei, a highly published and cited author based at the world's leading cancer research center in the United States. Dr. Wei's previous editorial work includes a role as a Senior Editor on the American Association for Cancer Research's journal Cancer Epidemiology, Biomarkers & Prevention. His research is aimed at identifying individuals at high risk of developing cancer.

Dr. Wei comments, "I am delighted to introduce Cancer Medicine, which will allow readers to have fast access to the most up to date global collaborations in cancer research and international approaches in practicing cancer medicine, as well as highlighting key achievements from the integration of basic, clinical and preventive research of cancer. In the years to come, I will work closely with the Wiley-Blackwell Cancer Medicine team to provide timely and impartial service to all contributors and readers, who will, without a doubt, make Cancer Medicine a success."


'/>"/>
Contact: Ben Norman
healthnews@wiley.com
44-012-437-70375
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. One Month after Major Quake, Ongoing Crises for Haitian Children
2. Virginia House Majority Leader Morgan Griffith Sponsors Legislation Enabling Mobile Solution for Health Care SALEM, Va.
3. Major milestone achieved by our joint venture in China
4. Sunquest Announces Major Software Updates and Enhancements
5. MIT China joint venture is preparing a major commercial launch in July 2010
6. Majority of Americans Approve of President Obamas Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television
7. Highlights of major physics conference in Washington, D.C.
8. The Icebox of Atlanta Selected as T-shirt Vendor for 3 Major Divisions of American Cancer Society's Relay For Life
9. Majority of Marylanders without advance medical directives
10. Pew Report Finds Majority of States Fail to Ensure Proper Dental Health & Access to Care for Children
11. Americans Remain Split on Stalled Health Care Legislation, but Some Provisions Popular Among Majorities of Democrats, Independents and Republicans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... ... broad access to life-saving drugs and rewarding the innovators who develop those drugs often ... , That was the message from Dana Goldman, PhD, Leonard D. Schaeffer Chair and ... who served as the keynote speaker for Western University of Health Sciences’ Ray Symposium ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between 2002 ... proportion of young people involved in violence in the United States. The study, ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke Therapy Programs , ... kicked off its 4th annual Forum for Innovative Treatment Solutions (FITS), which runs ... Therapy for Mental Health and Addiction.” , FITS’ 2017 keynote presenters will ...
(Date:4/21/2017)... ... April 21, 2017 , ... Young Asset Protection, ... to communities throughout the greater Pittsburgh metropolitan region, is joining forces with the ... bicycles for differently-abled children. , Variety the Children’s Charity is a national organization ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” applies ... project in the company’s esteemed VISION House demonstration project series. Manifesting the concept of ... of resources they need to live affordably and abundantly without unduly taxing the resources ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
Breaking Medicine Technology: